An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants.

Zheng YT, Jin XZ, Zhang CJ, Chen SS, Osterrieder N, Liu YM, Wang JC

Open source

DOI
10.1016/j.virusres.2026.199801
Published
2026 Sep 14
Container
Virus research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.virusres.2026.199801,
  title = {An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants.},
  author = {Zheng YT and Jin XZ and Zhang CJ and Chen SS and Osterrieder N and Liu YM and Wang JC},
  year = {2026},
  journal = {Virus research},
  doi = {10.1016/j.virusres.2026.199801},
  url = {https://doi.org/10.1016/j.virusres.2026.199801}
}

RIS

TY  - JOUR
TI  - An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants.
AU  - Zheng YT
AU  - Jin XZ
AU  - Zhang CJ
AU  - Chen SS
AU  - Osterrieder N
AU  - Liu YM
AU  - Wang JC
PY  - 2026
JO  - Virus research
DO  - 10.1016/j.virusres.2026.199801
UR  - https://doi.org/10.1016/j.virusres.2026.199801
ER  - 

APA

YT, Z., XZ, J., CJ, Z., SS, C., N, O., YM, L., & JC, W. (2026). An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants.. Virus research. https://doi.org/10.1016/j.virusres.2026.199801

Source records